Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Return on Sales: 2019-2024

Historic Return on Sales for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to 0.42%.

  • MDxHealth's Return on Sales rose 16.00% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.30%, marking a year-over-year increase of 19.00%. This contributed to the annual value of 0.42% for FY2024, which is 19.00% up from last year.
  • Latest data reveals that MDxHealth reported Return on Sales of 0.42% as of FY2024, which was up 31.15% from 0.61% recorded in FY2023.
  • Over the past 5 years, MDxHealth's Return on Sales peaked at 0.42% during FY2024, and registered a low of 1.55% during FY2020.
  • Moreover, its 3-year median value for Return on Sales was 0.61% (2023), whereas its average is 0.74%.
  • Per our database at Business Quant, MDxHealth's Return on Sales skyrocketed by 210bps in 2020 and then dropped by 12bps in 2022.
  • MRY analysis of 5 years shows MDxHealth's Return on Sales stood at 1.55% in 2020, then rose by 16bps to 1.30% in 2021, then grew by 9bps to 1.19% in 2022, then skyrocketed by 48bps to 0.61% in 2023, then surged by 31bps to 0.42% in 2024.
  • Its Return on Sales stands at 0.42% for FY2024, versus 0.61% for FY2023 and 1.19% for FY2022.